Braftovi
(Енкорафениб)
(75 mg)
(90)
(Capsules)
Брафтові / Braftovi (енкорафеніб) капс. 75 мг 90 caps. Generic, Bangladesh
In Stock
Indications
Encorafenib is indicated in combination with binimetinib for the treatment of adult patients with unresectable or metastatic melanoma with a BRAF V600E or V600K mutation and metastatic non-small cell lung cancer (NSCLC) with a BRAF V600E mutation. It is also indicated in combination with cetuximab for the treatment of adult patients with metastatic colorectal cancer with a BRAF V600E mutation.5
-
Commercial name:Braftovi
-
Сhemical name:Енкорафениб
-
Dosage:75 mg
-
Quantity:90
-
Release form:Capsules
-
Производитель:Бангладешь, Lucius
No reviews yet